Satellite Symposium:
New Biomarkers for Early Risk Assessment of AKI: Solving the Challenge
- Location: Horta Room
- Chairperson: John Kellum (Pittsburgh, USA)
- Time: March 20, 2013 at 12:30
Programme (12:30-13:30)
- Welcome and Introduction - John Kellum (Pittsburgh, USA)
- Cell Cycle Arrest Biomarkers for AKI - Lakhmir Chawla (Washington, USA)
- Pathogenesis of AKI - John Kellum (Pittsburgh, USA)
- Implications for Management of AKI - Andrew Shaw (Durham, USA)
- Questions and Answers
About Astute Medical
Astute Medical is committed to improving patient outcomes through the identification and validation of unique, new biomarkers. Our measurement methods help rapidly assess high-risk acute medical problems and diseases. By incorporating useful clinical tools, we help health care professionals more readily perform risk assessment for elderly and critically ill patients. And because our tools produce test results for risk assessment within minutes, they position physicians to provide rapid, accurate and life-saving responses.To find out more please visit Astute Medical at ISICEM 2013, stand nr. 2.65 - 2.68 or visit: www.astutemedical.com/Europe
Latest Articles
AKI, Biomarkers, ISICEM2013, AstuteMedical
Satellite Symposium: New Biomarkers for Early Risk Assessment of AKI: Solving the ChallengeLocation: Horta RoomChairperson: John Kellum (Pittsburgh, USA)T...